Skip to content
Home/Companies/Biotech/Ocellaris Pharma

Ocellaris Pharma

Biotech·Canada·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Ocellaris Pharma?

Ocellaris Pharma is currently owned by TVM Capital Life Science through TVM Life Science Innovation (2016 vintage), since 2019.

Hand-verified · updated 2026-08-11

TVM Capital Life Science
Investor
TVM Capital Life Science
TVM Life Science Innovation · 2016 · VC

Key facts

HQCanada
SectorBiotech
StatusActive

More from TVM Life Science Innovation

Other portfolio companies in the same fund.

Anciata Therapeutics, Inc.
Active
BiotechUnited States· 2025
LAmAb Biologics, Inc.
Active
BiotechUnited States· 2023
Mage Biologics, Inc.
Active
BiotechUnited States· 2023
Recurv Pharma, Inc.
Active
BiotechUnited States· 2023
Auricula Biosciences
Active
BiotechUnited States· 2022
Immunorx Pharma, Inc.
Active
BiotechUnited States· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Ocellaris Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Ocellaris Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue